Table 3.
Clinicopathological Characteristics of Breast Cancer Patients
| Parameters | 110 | |
|---|---|---|
| Age Group | ||
| Age >40 | 70 | 63.63% |
| Age<40 | 40 | 26.37% |
| Stage status | ||
| Early (I and II) | 35 | 31.82% |
| Advanced (III and IV) | 75 | 68.18% |
| Grade I vs Grade II | ||
| Grade I | 10 | 9.09% |
| Grade II | 32 | 29.00% |
| Grade III | 68 | 61.81% |
| Estrogen receptor status | ||
| Positive | 62 | 56.37% |
| Negative | 48 | 43.63% |
| Progesterone Receptor status | ||
| Positive | 72 | 65.45% |
| Negative | 38 | 34.55% |
| Her2/neu status | ||
| Positive | 45 | 40.90% |
| Negative | 65 | 59.10% |
| Distant metastasis status | ||
| Positive | 78 | 70.90% |
| Negative | 32 | 29.10% |
| Herceptin treatment | ||
| Herceptin | 30 | 27.27% |
| No Herceptin | 80 | 72.73% |
| Tamoxifen treatment | ||
| Tamoxifen | 67 | 60.90% |
| No Tamoxifen | 43 | 39.10% |
| Mastectomy treatment | ||
| Mastectomy | 33 | 30.00% |
| No Mastectomy | 77 | 70.00% |
| Lumpectomy Surgery | ||
| Lumpectomy | 24 | 21.81% |
| No Lumpectomy | 86 | 78.18% |